Navigation Links
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
Date:5/31/2012

nce and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. 

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and future business decisions made by us and our competitors.  All of these factors are difficult or impossible to predict accurately and many of them are beyond our control.  For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A – Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A – Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter.  We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.  This cautionary statement is applicable to all forward-looking statements contained in this document.


'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015   Vincari , known ... , has just hired John O,Neil as ... John has over 30 years of diverse and progressive ... O,Neil,s executive healthcare experience coupled with Vincari,s CMO, Dr. ... allows Vincari to address the challenges both hospitals and ...
(Date:7/28/2015)... ALBANY, New York , July 28, 2015 ... of a new report, titled " Cancer Diagnostics ... Forecast, 2014 - 2020 " . According to this ... at a CAGR of 7.6% during the forecast period of ... was valued at US$100,994.5 million and is expected to be ...
(Date:7/28/2015)... 2015   CSL Behring announced today ... Authorization Application (MAA) for the company,s investigational long-acting ... recombinant albumin (rIX-FP) for the prophylaxis and treatment ... Upon Swissmedic approval, rIX-FP will provide hemophilia B ... intervals up to 14 days. ...
Breaking Medicine Technology:John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
... 2010 Reportlinker.com announces that a new market research ... Chinese Markets for Drug Delivery System ... demand for Drug Delivery System has grown at a ... five years, both production and demand will continue to ...
... GARDENS, Fla., Dec. 9, 2010 The national media keeps ... results of the NYU one-year research study on pediatric dosing ... Journal of the American Medical Association ,s December issue. The ... top children,s liquid medications, found inconsistencies across all the medications, ...
Cached Medicine Technology:Reportlinker Adds Chinese Markets for Drug Delivery System 2Reportlinker Adds Chinese Markets for Drug Delivery System 3Reportlinker Adds Chinese Markets for Drug Delivery System 4Reportlinker Adds Chinese Markets for Drug Delivery System 5AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 2AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 3
(Date:7/28/2015)... ... July 29, 2015 , ... City Sports, a specialty sports retailer and ... executive Marty Hanaka as CEO. , Hanaka, who has served on the Board of ... partner at the Highland Consumer Fund has had previous tenures as Chairman and CEO ...
(Date:7/28/2015)... West Jordan, Utah (PRWEB) , ... July 28, ... ... Medical Center West Valley Campus have received the Get With The Guidelines®-Stroke Gold ... Association for excellence in patient care and outcomes. , The Get With ...
(Date:7/28/2015)... Rolling Meadows, Ill. (PRWEB) , ... July 28, 2015 , ... ... has been commended with a national 2015 Power of A award for “helping to ... named a Power of A Gold Award winner by the American Society of Association ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... navigation, portal to access industry practices, consumer education, resource library, floor plans, educational ... from around the globe and offers regular posts with valuable links to useful ...
(Date:7/28/2015)... Richey, FL (PRWEB) , ... July 28, 2015 ... ... University and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance ... the latter group was more likely to relapse to opiate use (1) and ...
Breaking Medicine News(10 mins):Health News:City Sports Names Marty Hanaka CEO 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 2Health News:Jordan Valley Medical Center and Jordan Valley Medical Center West Valley Campus Receive Stroke Award 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4
... Komen NC Triangle Affiliate Joins Nationwide Campaign to Close ... Low-Income Women and Women of Color, RALEIGH, N.C., ... G. Komen for the Cure today joined Governor Easley ... proclamation and a,Monday evening Executive Mansion reception with First ...
... Evening Will Feature Special Performances by John Legend, Joss Stone, ... Patti ... G&P Foundation for Cancer,Research will honor four outstanding individuals at the ... Officer of BET Networks Debra L. Lee, Chief Hematologic Oncology,Memorial Sloan-Kettering ...
... researchers say , TUESDAY, Oct. 16 (HealthDay News) -- ... and sashimi -- increases the risk of infection by ... stomach and intestinal problems such as diarrhea, cramping, and ... department, say two cases studies by Japanese researchers. , ...
... 2007 -- Scientists have shown how developing brain tumors can ... experience for the tumor cells into a cue for their ... of Medicine in St. Louis found the transformation relies on ... existing drugs, opening the possibility that they may be able ...
... pylori has been extensively studied and proven to be the ... HIV-negative population. Patients with chronic active gastritis have evidence of ... 70-100% of those with peptic ulcer disease. However, the reason ... was still not very clear. A study examining this issue ...
... are diagnosed with breast cancer is predicting the likelihood ... the body metastasize. Researchers from UC San Diego ... Ideker is pioneering a more accurate approach for predicting ... , This work will be published online by the ...
Cached Medicine News:Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 2Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 3Health News:Susan G. Komen for the Cure Launches Komen Community Challenge With Governor's Pink Ribbon Week Proclamation and Executive Mansion Reception 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 2Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 3Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 4Health News:The G&P Foundation Celebrates 10 Years of Funding Life Saving Research at The 2007 Angel Ball Honoring Glenda Bailey, Debra L. Lee, Dr. Stephen D. Nimer and the Late H.H. Sheik Zayed Bin Sultan Al Nahyan 5Health News:Raw Seafood Poses Digestive Risks 2Health News:Study suggests existing drugs may be useful in treating brain tumors 2Health News:Study suggests existing drugs may be useful in treating brain tumors 3Health News:A low prevalence of H pylori in HIV-positive patients 2Health News:UC San Diego researchers improve accuracy of breast cancer prognoses 2Health News:UC San Diego researchers improve accuracy of breast cancer prognoses 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
Severe revision options for the knee and hip...
Severe revision options for the knee and hip...
Medicine Products: